72F fusion protein vaccine
72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the and proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
72F fusion protein vaccine
72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the and proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
has abstract
72F fusion protein vaccine is ...... d Phase II trials are awaited.
@en
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
950,428,642
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
hypernym
type
comment
72F fusion protein vaccine is ...... d Phase II trials are awaited.
@en
label
72F fusion protein vaccine
@en